PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.
Muniyan S, Vengoji R, Nimmakayala RK, Seshacharyulu P, Perumalsamy B, Alsafwani ZW, Kakar SS, Smith LM, Shonka N, Teply BA, Lele SM, Ponnusamy MP, Batra SK.
Muniyan S, et al. Among authors: batra sk.
Cancer Lett. 2024 Nov 25:217355. doi: 10.1016/j.canlet.2024.217355. Online ahead of print.
Cancer Lett. 2024.
PMID: 39603380